Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

EQUIFAX INC (EFX)

CIK 0000033185 2 material events

Insider activity (SEC Form 4)

Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.

Open-market · last 30 days: 0 buyers bought $0 1 seller sold $846K
Open-market · last 90 days: 0 buyers bought $0 2 sellers sold $7.4M
InsiderRoleDateTransactionSharesValue
GAMBLE JOHN W JR EVP, CFO & COO 2026-09-03 Open-market sell 10b5-1 4500 $846K
Begor Mark W CEO, Director 2026-07-24 Option exercise 10b5-1 37791 $4.2M
Begor Mark W CEO, Director 2026-07-24 Open-market sell 10b5-1 500 $88K
Begor Mark W CEO, Director 2026-07-24 Open-market sell 10b5-1 600 $102K
Begor Mark W CEO, Director 2026-07-24 Open-market sell 10b5-1 600 $101K
Begor Mark W CEO, Director 2026-07-24 Open-market sell 10b5-1 1300 $227K
Begor Mark W CEO, Director 2026-07-24 Open-market sell 10b5-1 2936 $510K
Begor Mark W CEO, Director 2026-07-24 Open-market sell 10b5-1 4112 $711K
Begor Mark W CEO, Director 2026-07-24 Open-market sell 10b5-1 6200 $1.1M
Begor Mark W CEO, Director 2026-07-24 Open-market sell 10b5-1 21543 $3.7M
Borton Chad M EVP, Pres Workforce Solutions 2026-05-07 Open-market sell 10b5-1 2455 $427K
FEIDLER MARK L Director 2026-05-07 Grant/award 1253 $220K
Fichuk Karen L Director 2026-05-07 Grant/award 1253 $220K
HOUGH G. THOMAS Director 2026-05-07 Grant/award 1253 $220K
Larson Barbara A Director 2026-05-07 Grant/award 1253 $220K
MARCUS ROBERT D Director 2026-05-07 Grant/award 1253 $220K
MCGREGOR SCOTT A Director 2026-05-07 Grant/award 1253 $220K
McKinley John A Director 2026-05-07 Grant/award 1253 $220K
Smith Melissa D Director 2026-05-07 Grant/award 1253 $220K
TILLMAN AUDREY B Director 2026-05-07 Grant/award 1253 $220K
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.

Risk Radar (year-over-year Risk Factors)

← All Risk Radar

Fiscal period ending 2025-12-31 versus 2024-12-31view filing on EDGAR →

A cluster of newly disclosed risks — IP licensing dependency, AI competitive pressure, and expanded geopolitical/trade exposure — meaningfully widens the company's risk profile across multiple dimensions. The IP licensing disclosures are particularly notable: loss of key partner rights now threatens both revenue retention and customer relationships simultaneously. Tariff, trade restriction, and AI regulatory risks add further headwinds with no offsetting easing disclosed.

1 company-specific · 4 common-mode

Company-specific changes

Revised

Added new risk: insourcing/transitioning to domestic vendors could cause significant costs and adversely impact operations. Broadened geopolitical risk scope beyond developing countries.

Dependence on outsourcing certain portions of our operations may adversely affect our ability to bring products to market and damage our reputation. Dependence on outsourced information technology…

Also disclosed — common-mode (Third party AI vendor dependency ×2, Generative AI competition disruption, Tariffs trade policy)
Third party AI vendor dependency Revised

New disclosure of material revenue dependency on licensed IP from key partners; non-renewal risk could force customers to competitors or direct partners.

If our relationships with key customers and business partners are materially diminished or terminated, our business could suffer. We have long-standing relationships with a number of our customers…

Third party AI vendor dependency Revised

Added explicit dependency on third-party intellectual property licensing; loss of IP rights now disclosed as material revenue risk alongside data access loss.

The loss of access to credit, employment, financial and other data or intellectual property from external sources could harm our ability to provide our products and services. We rely extensively on…

Generative AI competition disruption Revised

Added explicit AI capability risks, accelerated product introduction pressure, and new operational strain disclosure. Escalates competitive and execution risk.

If we do not introduce successful new products and services in a timely manner, or if the market does not adopt our products and services, or if new technologies and analytical capabilities are…

Tariffs trade policy Revised

Added explicit tariff and trade restriction risk; added AI regulatory risk. Both represent newly disclosed, substantive business risks.

Global Operational Risks Economic, political and other risks associated with international sales and operations could adversely affect our results of operations. Sales outside the U.S. comprised 23%…

Material year-over-year changes to this company's Risk Factors (Item 1A), found by comparing each annual report to the prior year, judged for materiality, and classified as company-specific or common-mode against the cross-company catalog. Common-mode changes are the macro themes many companies disclose in common; they are collapsed above. A filing marked unchanged had no material change from the prior year; its summary describes the company's standing risks, which remain in force. Fiscal periods are the reporting period ends. Not investment advice.

Debt Issuance

8-K filed 2026-07-29 confidence 95% Item 8.01

Equifax issued $1 billion in aggregate principal amount of senior notes ($500M due 2029 at 5.000% and $500M due 2033 at 5.650%), creating a direct financial obligation. The disclosure details the underwriting agreement, indenture terms, interest rates, maturity dates, and redemption provisions. Net proceeds of approximately $990.5 million are intended for repayment of commercial paper borrowings. This is a material debt issuance under Item 2.03 (or Item 8.01 as filed here).

View raw filing on EDGAR →

Earnings release

8-K filed 2026-07-21 confidence 98% Item 2.02

This is a clear earnings release disclosing Equifax's financial results for the second quarter ended June 30, 2026. The press release (Exhibit 99.1) presents quarterly revenue of $1.700 billion (up 11%), net income, diluted EPS, segment results, and forward guidance for Q3 and full-year 2026. The Item 2.02 disclosure explicitly states the company "issued a press release disclosing financial results for the three month period ended June 30, 2026," which is the hallmark of an earnings_release event.

View raw filing on EDGAR →